EDSA (EDSA) Stock Price & Analysis
EDSA (EDSA) fell 0.63% to USD 4.73 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
EDSA last closed at USD 4.73; the session ranged USD 4.72–4.97 on volume of 36,375 shares. Market capitalization is —, with a 52-week range of USD 0.72–20.32 (NCM). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 4.73 |
|---|---|
| Change | ▼ 0.63% (down) |
| Previous Close | USD 4.73 |
| Open | USD 4.73 |
| Day Range | USD 4.72 – 4.97 |
| 52-Week Range | USD 0.72 – 20.32 |
| Volume | 36,375 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (EDSA)
Nexqual's technical model rates EDSA "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.51 (neutral) |
| vs SMA50 | Below (USD 5.79) |
| MACD | -0.29 (negative) |
From EDSA's Latest SEC 10-K Filing (filed 2025-12-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | USD 14.39 | ▲ 1.34% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 2.71% |
| IMRN | Immuron Limited | USD 1.8 | ▲ 53.85% |
| ATHE | Alterity Therapeutics Limited | USD 4.54 | ▲ 0.44% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.